Literature DB >> 16354682

Distinct roles of phosphoinositide-3 kinase and phospholipase Cgamma2 in B-cell receptor-mediated signal transduction.

Xuezhi Dai1, Yuhong Chen, James Schuman, Zichun Hua, John W Adamson, Renren Wen, Demin Wang.   

Abstract

During B-cell receptor (BCR) signaling, phosphoinositide-3 kinase (PI3K) is thought to function upstream of phospholipase Cgamma2 (PLCgamma2). PLCgamma2 deficiency specifically impedes transitional type 2 (T2) to follicular (FO) mature B-cell transition. Here, we demonstrate that PI3K deficiency specifically impaired T2-to-FO mature B-cell transition and marginal zone B-cell development. Furthermore, we investigated the functional relationship between PI3K and PLCgamma2 using PI3K-/-, PLCgamma2-/-, and PI3K-/- PLCgamma2-/- B cells. Interestingly, PLCgamma2 deficiency had no effect on BCR-mediated PI3K activation, whereas PI3K deficiency only partially blocked activation of PLCgamma2. Moreover, whereas PI3K-/- PLCgamma2-/- double deficiency did not affect hematopoiesis, it resulted in embryonic lethality. PI3K-/- PLCgamma2-/- fetal liver cells transplanted into B-cell null JAK3-/- mice failed to restore development of peripheral B cells and failed to progress through early B-cell development at the pro-B- to pre-B-cell transition, a more severe phenotype than was observed with either PI3K or PLCgamma2 single-deficiency B cells. Consistent with this finding, BCR signaling was more severely impaired in the absence of both PI3K and PLCgamma2 genes than in the absence of either one alone. Taken together, these results demonstrate that whereas PI3K functions upstream of PLCgamma2, activation of PLCgamma2 can occur independently of PI3K and that PI3K and PLCgamma2 also have distinct functions in BCR signal transduction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16354682      PMCID: PMC1317611          DOI: 10.1128/MCB.26.1.88-99.2006

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  76 in total

1.  Mutation of the pleckstrin homology domain of Bruton's tyrosine kinase in immunodeficiency impaired inositol 1,3,4,5-tetrakisphosphate binding capacity.

Authors:  M Fukuda; T Kojima; H Kabayama; K Mikoshiba
Journal:  J Biol Chem       Date:  1996-11-29       Impact factor: 5.157

Review 2.  Regulation of phosphoinositide-specific phospholipase C isozymes.

Authors:  S G Rhee; Y S Bae
Journal:  J Biol Chem       Date:  1997-06-13       Impact factor: 5.157

Review 3.  PI3K: downstream AKTion blocks apoptosis.

Authors:  T F Franke; D R Kaplan; L C Cantley
Journal:  Cell       Date:  1997-02-21       Impact factor: 41.582

Review 4.  Akt signaling: linking membrane events to life and death decisions.

Authors:  B A Hemmings
Journal:  Science       Date:  1997-01-31       Impact factor: 47.728

5.  Naturally occurring dominant negative variants of Stat5.

Authors:  D Wang; D Stravopodis; S Teglund; J Kitazawa; J N Ihle
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

6.  Mechanism of activation of protein kinase B by insulin and IGF-1.

Authors:  D R Alessi; M Andjelkovic; B Caudwell; P Cron; N Morrice; P Cohen; B A Hemmings
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

7.  Vav in natural killer cells is tyrosine phosphorylated upon cross-linking of Fc gamma RIIIA and is constitutively associated with a serine/threonine kinase.

Authors:  X Xu; A S Chong
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

8.  Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase.

Authors:  K Salim; M J Bottomley; E Querfurth; M J Zvelebil; I Gout; R Scaife; R L Margolis; R Gigg; C I Smith; P C Driscoll; M D Waterfield; G Panayotou
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

9.  P110delta, a novel phosphoinositide 3-kinase in leukocytes.

Authors:  B Vanhaesebroeck; M J Welham; K Kotani; R Stein; P H Warne; M J Zvelebil; K Higashi; S Volinia; J Downward; M D Waterfield
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

10.  Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice.

Authors:  Klaus Okkenhaug; Antonio Bilancio; Géraldine Farjot; Helen Priddle; Sara Sancho; Emma Peskett; Wayne Pearce; Stephen E Meek; Ashreena Salpekar; Michael D Waterfield; Andrew J H Smith; Bart Vanhaesebroeck
Journal:  Science       Date:  2002-07-18       Impact factor: 47.728

View more
  5 in total

Review 1.  The follicular versus marginal zone B lymphocyte cell fate decision.

Authors:  Shiv Pillai; Annaiah Cariappa
Journal:  Nat Rev Immunol       Date:  2009-11       Impact factor: 53.106

2.  The viral latency-associated nuclear antigen augments the B-cell response to antigen in vivo.

Authors:  Sang-Hoon Sin; Farnaz D Fakhari; Dirk P Dittmer
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

3.  Deletion of PI3K-p85alpha gene impairs lineage commitment, terminal maturation, cytokine generation and cytotoxicity of NK cells.

Authors:  A Awasthi; A Samarakoon; X Dai; R Wen; D Wang; S Malarkannan
Journal:  Genes Immun       Date:  2008-06-12       Impact factor: 2.676

Review 4.  Antigen receptor signalling: a distinctive role for the p110delta isoform of PI3K.

Authors:  Klaus Okkenhaug; Khaled Ali; Bart Vanhaesebroeck
Journal:  Trends Immunol       Date:  2007-01-05       Impact factor: 16.687

5.  PLCγ-dependent mTOR signalling controls IL-7-mediated early B cell development.

Authors:  Mei Yu; Yuhong Chen; Hu Zeng; Yongwei Zheng; Guoping Fu; Wen Zhu; Ulrich Broeckel; Praful Aggarwal; Amy Turner; Geoffrey Neale; Cliff Guy; Nan Zhu; Hongbo Chi; Renren Wen; Demin Wang
Journal:  Nat Commun       Date:  2017-11-13       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.